Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions

Details for Australian Patent Application No. 2004208962 (hide)

Owner to-BBB Holding B.V.

Inventors Brink, Arjen; Gaillard, Pieter Jaap; De Boer, Albertus Gerrit

Agent Griffith Hack

Pub. Number AU-B-2004208962

PCT Pub. Number WO2004/069870

Priority 60/446,270 11.02.03 US; 60/491,522 01.08.03 US; 03075390.9 10.02.03 EP

Filing date 10 February 2004

Wipo publication date 19 August 2004

Acceptance publication date 15 July 2010

International Classifications

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/069870 Priority application(s): WO2004/069870

15 July 2010 Application Accepted

  Published as AU-B-2004208962

11 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004208967-Templated cluster assembled wires

2004208961-Control of plant growth and developmental processes